iBio, Inc. financial data

Symbol
IBIO on NYSE
Industry
Pharmaceutical Preparations
Location
600 Madison Avenue, Suite 1601, New York, NY
State of incorporation
Delaware
Fiscal year end
June 30
Former names
iBioPharma, Inc. (to 8/14/2009), InB:Biotechnologies, Inc. (to 7/17/2008)
Latest financial report
10-Q - Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 123 % -20.1%
Quick Ratio 0 %
Debt-to-equity 160 % +79.7%
Return On Equity -205 % -487%
Return On Assets -109 % -336%
Operating Margin -53.6K % -2906%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.62M shares -48.7%
Common Stock, Shares, Outstanding 8.52M shares -31.1%
Entity Public Float 5.44M USD -95.5%
Common Stock, Value, Issued 9K USD -43.8%
Weighted Average Number of Shares Outstanding, Basic 3.71M shares +463%
Weighted Average Number of Shares Outstanding, Diluted 3.71M shares +463%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 50K USD -97.2%
Revenue from Contract with Customer, Excluding Assessed Tax 50K USD
Research and Development Expense 6.4M USD -44.5%
General and Administrative Expense 11.8M USD -49.2%
Operating Income (Loss) -18.2M USD +47.8%
Nonoperating Income (Expense) 1.06M USD +1484%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -76M USD -129%
Earnings Per Share, Basic 70.7 USD/shares +92.3%
Earnings Per Share, Diluted 70.7 USD/shares +92.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.3M USD -19.2%
Cash, Cash Equivalents, and Short-term Investments 6.43M USD -34.5%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Inventory, Net 0 USD
Assets, Current 36.1M USD +33.4%
Property, Plant and Equipment, Net 3.73M USD -14.5%
Operating Lease, Right-of-Use Asset 2.47M USD -11.3%
Intangible Assets, Net (Excluding Goodwill) 5.37M USD -0.37%
Assets 50.2M USD +13%
Accounts Payable, Current 1.23M USD -39%
Employee-related Liabilities, Current 3.35M USD +9.33%
Accrued Liabilities, Current 4M USD +4.63%
Contract with Customer, Liability, Current 175K USD
Liabilities, Current 21.4M USD -3.82%
Operating Lease, Liability, Noncurrent 2.8M USD -13.1%
Liabilities 25.3M USD -6.32%
Accumulated Other Comprehensive Income (Loss), Net of Tax -167K USD -83.5%
Retained Earnings (Accumulated Deficit) -306M USD -8.19%
Stockholders' Equity Attributable to Parent 24.9M USD +43%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 24.9M USD +43%
Liabilities and Equity 50.2M USD +13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.34M USD +61.7%
Net Cash Provided by (Used in) Financing Activities 2.47M USD +117%
Net Cash Provided by (Used in) Investing Activities 50K USD +72.4%
Common Stock, Shares Authorized 275M shares 0%
Common Stock, Shares, Issued 8.52M shares -46.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.82M USD +78%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.43M USD -34.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 200K USD +6.95%
Deferred Tax Assets, Valuation Allowance 49.6M USD +34.8%
Depreciation 165K USD -39.1%
Payments to Acquire Property, Plant, and Equipment 2.48M USD +121%
Lessee, Operating Lease, Liability, to be Paid 3.23M USD -10.5%
Property, Plant and Equipment, Gross 4.62M USD +0.57%
Operating Lease, Liability, Current 424K USD +12.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 476K USD +12.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 424K USD +12.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 532K USD +11.8%
Deferred Tax Assets, Operating Loss Carryforwards 43M USD +19.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 593K USD +11.5%
Operating Lease, Payments 564K USD -5.37%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 20K USD -89.4%
Share-based Payment Arrangement, Expense 2.11M USD -39.6%
Interest Expense 52K USD +48.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%